Daratumumab, Venetoclax, and Azacitidine in Combination with the HAA Regimen as Consolidation Chemotherapy for T-Cell Acute Lymphoblastic Leukemia with High CD38 Expression
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Turkish Society of Hematology
2025-09-01
|
| Rangatū: | Turkish Journal of Hematology |
| Ngā marau: | |
| Urunga tuihono: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-82150 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|